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Preliminary and Short Report
THE ANTICRYPTOCOCCAL FACTOR OF BLOOD SERUM
A PRELIMINARY REPORT*
GEORGE SZILAGYI, M.D.,55 FREDERICK REI5S, M.D.55 AND JOHN CRI5PIN SMITH, PH.D.S**
Reports (1, 2, 3) in the literature indicate that
human blood sera inhibit the growth of C. neo-
formens. There are also indications that persons
with malignant diseases are prone to infection with
this organism (4, 5, 6). In view of the aforemen-
tioned we will attempt to determine variations of
antieryptococcal factors in healthy persons as well
as in persons with malignancies. The present re-
port concerns the anticryptococcal factor of clini-
cally healthy persons, and an attempt of its deter-
mination and characterization.
METHODS AND MATERIALS
Clotted human sera randomly obtained from
clinically healthy persons were sterilized by passing
through a Swinney hypodermic adapter. The sera
were prefiltered through a microfiber glass. This was
followed by filtration through a Millipore filter,
with pores of 0.45 diameter. Sera were stored in
the frozen state. The test organism was isolated
from a human ease of cryptococcosis and grown on
Sabouraud dextrose agar.t The culture was har-
vested, washed twice and suspended in Littman's
cryptococcus capsule medium. The suspension was
adjusted to 0.5 optical density, at 650 millimicron
in a Coleman Junior Spectrophotometer. Littman's
eryptococcus capsule broth was used as a basal
medium for the demonstration of growth inhibition
of C. neoformons by human serum.
a. The effect of serum on growth of C. neoformans
Serum was added in amounts varying from 0.1
to 1.0 ml to Littman's capsule broth so that the
final volume was 3.5 ml. These tubes were inocu-
lated with 0.1 ml of spectrophotometrically stand-
ardized C. neoformanst suspension. This was in-
cubated at 37°C and agitated twice daily. Growth
rate was determined every second day for the first
three weeks by reading the optical density in a
Coleman Junior Spectrophotometer. Readings were
made after the instrument was adjusted to 100%
transmission with blank (basal medium mixed with
serum) in optical system. Control growth rates were
determined as above except that the serum was
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omitted from the media. To keep the volumes
identical, 3, 5, ml of Littman's capsule broth was
used. This procedure was applied in studies out-
lined under b, c, e.
b. 7'he effect of temperature on growth
inhibitory factor
In these experiments conditions were kept as
under (a.) except that the blood serum was pre-
heated at 37°C, 56°C, and 62°C for 30 minutes be-
fore adding to the culture medium.
c. The role of iron binding factor in growth
inhibition of C. neoformans by normal
human serum
In order to determine whether the inhibitory
property of serum is due to its iron binding factor,
the following tests were carried out:
1. Serum, which in a previous test was found
to be strongly inhibitory, was used in this test.
Culture medium was prepared as under (a.) ex-
cept that ferrous ammonium sulfate was added in
such amounts, that each tube contained the equiv-
alent of 5 meg of iron.
2. The same as in (1.) except that the serum
used was weakly inhibitory.
d. The role of specific antibodies in growth
inhibition of C. neoformans by normal
human Serum
Cryptococcus agglutination test was carried out
on 7 sera (5 showed inhibition of C. neoformans
and 2 did not) according to the method recom-
mended by Dr. Morris Gordon of N. Y. State Dept.
of Health.
e. Inhibitory effect of serum protein fractions
Serum protein fractions obtained by column
electrophoresis on cellulose were used in this test.
The protein fractions so obtained were dialyzed
against water and then lyophilized. When used in
the test they were redissolved in 0.85% saline
solution. The protein fractions tested were: pre—
albumin, albumin, albumin + alpha 1 globulin,
alpha 2 globulin, beta globulin, gamma 1 and
gamma 2 globulins. Tests were conducted as in
(a.) except that protein fractions were substituted
for serum.
RESULTS
The results obtained with 14 sera randomly col-
lected and tested for inhibition are given in Table
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I. A 50% inhibition of growth was considered sig-
nificant. The maximum inhibition of growth oc-
curred between the sixth and eighth day of
incubation. After that period there was a rapid in-
crease in growth, approaching that of control.
To produce 50% inhibition at least 13% serum
had to be incorporated in the medium. The in-
hibition is shown in Fig. 1. Complete inhibition
was not obtained by increasing the amount of
serum added to the culture medium. The effect of
heat treatment on inhibition is shown in Fig. 2.
The growth at room temperature and at 37°C was
the same. Preheating the serum to 56°C for 30
minutes slightly reduced its inhibitory activity.
TABLE I
Illustrating the rate of inhibition by randomly
col/ected sera from healthy subjects
Serum S % Irthibition
63 21
7 25
5 29
17 38
15 42
6 42
62 50
65 54
72 54
18 57
19 60
13 63
14 67
82 71
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Fia. 1. The effect of serum concentration on growth inhibition of C. neoformans
Heating the serum to 62°C for 30 minutes de-
stroyed its inhibitory activity.
Fig. 3. gives the results of addition of iron to
serum on its inhibitory activity. Adding 5 meg of
iron per assay to a very active serum, reversed its
inhibitory property. Adding the same amount of
iron to a low inhibitory serum, did not reverse the
inhibition. From these data one may assume that
-l24 37 56 62
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Fia. 2. The effect of temperature
hibitory activity of human serum.
308 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Protein fraction % Inhibition
Whole serum 60
Prealbumin 10
Albumin 6
Albumin + alpha 1 globulin 6
Alpha 2 globulin 73
Beta globulin 0
Gamma 1 globulin 7
Gamma 2 globulin 80
in addition to the iron binding factor of serum,
(7) other factors may be involved in the inhibi-
tory activity of serum.
Growth inhibition of C. neoJorman.s by serum
protein fractions is presented in Table II. It was
observed that the fractions with significant ac-
tivity are found in the regions of alpha 2 and
gamma 2 globulin.
No specific antibodies were demonstrated by
cryptococcus agglutination test performed on both
inhibitory and non-inhibitory sera.
Further investigations are being carried out to
demonstrate the presence of the anticryptococcal
factor in blood of different mammalian species and
patients with malignancies and, furthermore, to
determine exactly the factor or factors responsible
for growth inhibition of C. neoformons.
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FIG. 3. Reversal of inhibitory activity by iron
TABLE II
The role of anticryptococcus activity of various
serum protein fractions
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